Shilu D. Thomas
Al Ain, AZ, United Arab Emirates
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Simultaneous inhibition of cholinesterase and antagonism of histamine H3 receptors alleviates cognitive deficits and mitigates apoptosis in scopolamine-induced amnesia in mice.
Journal: Frontiers in behavioral neuroscience
Published: October 10, 2025
The Emerging Role of Phosphodiesterase Inhibitors in Fragile X Syndrome and Autism Spectrum Disorder.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 08, 2025
Alleviation of Autophagic Deficits and Neuroinflammation by Histamine H3 Receptor Antagonist E159 Ameliorates Autism-Related Behaviors in BTBR Mice.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 09, 2024
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum Disorder.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 15, 2024
Simultaneous Antagonism at H3R/D2R/D3R Reduces Autism-like Self-Grooming and Aggressive Behaviors by Mitigating MAPK Activation in Mice.
Journal: International journal of molecular sciences
Published: November 23, 2022
mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder.
Journal: Molecules (Basel, Switzerland)
Published: October 05, 2022
Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin.
Journal: Nutrients
Published: October 05, 2022
Repurposing Dimethyl Fumarate for Cardiovascular Diseases: Pharmacological Effects, Molecular Mechanisms, and Therapeutic Promise.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 18, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026